- Updated Phase 1 Clinical Trial Outcomes of CRISPR Gene Editing With Nexiguran Ziclumeran In Patients With Transthyretin Amyloidosis With Cardiomyopathy
-
211-213FS.10
Generic 'disconnected' Message4391511
Disclosures:
Scott Solomon: Financial relationships have not been disclosed at this time. | Brian Claggett: Financial relationships have not been disclosed at this time. | Marianna Fontana: Financial relationships have not been disclosed at this time. | Julian D Gillmore: Financial relationships have not been disclosed at this time. | Edward Gane: Financial relationships have not been disclosed at this time. | Bjorn Pilebro: Financial relationships have not been disclosed at this time. | David Adams: Financial relationships have not been disclosed at this time. | Jessica Kachadourian: Financial relationships have not been disclosed at this time. | Ricardo Rocha: Financial relationships have not been disclosed at this time. | Joy Olbertz: Financial relationships have not been disclosed at this time. | Peijuan Zhu: Financial relationships have not been disclosed at this time. | Carri Boiselle: Financial relationships have not been disclosed at this time. | Derek Smith: Financial relationships have not been disclosed at this time. | Adia Leung: Financial relationships have not been disclosed at this time. | Alison Sonderfan: Financial relationships have not been disclosed at this time. | Liron Walsh: Financial relationships have not been disclosed at this time. | Jorg Taubel: Financial relationships have not been disclosed at this time. | David Gutstein: Financial relationships have not been disclosed at this time. | Alexandra Haagensen: Financial relationships have not been disclosed at this time. |CommunitiesNavigationProgram SelectionSession Type
Enter Note
Go to previous page in this tab
Session